BE895718A - Composition d'anthralines dans un ester aromatique et utilisation dans le traitement des maladies de la peau et des ongles - Google Patents

Composition d'anthralines dans un ester aromatique et utilisation dans le traitement des maladies de la peau et des ongles

Info

Publication number
BE895718A
BE895718A BE0/209979A BE209979A BE895718A BE 895718 A BE895718 A BE 895718A BE 0/209979 A BE0/209979 A BE 0/209979A BE 209979 A BE209979 A BE 209979A BE 895718 A BE895718 A BE 895718A
Authority
BE
Belgium
Prior art keywords
skin
treatment
aromatic ester
nail diseases
anthralin
Prior art date
Application number
BE0/209979A
Other languages
English (en)
French (fr)
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BE895718A publication Critical patent/BE895718A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE0/209979A 1982-01-28 1983-01-27 Composition d'anthralines dans un ester aromatique et utilisation dans le traitement des maladies de la peau et des ongles BE895718A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8201327A FR2520233A1 (fr) 1982-01-28 1982-01-28 Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau

Publications (1)

Publication Number Publication Date
BE895718A true BE895718A (fr) 1983-07-27

Family

ID=9270406

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/209979A BE895718A (fr) 1982-01-28 1983-01-27 Composition d'anthralines dans un ester aromatique et utilisation dans le traitement des maladies de la peau et des ongles

Country Status (10)

Country Link
US (1) US4504494A (enExample)
JP (1) JPS58134025A (enExample)
AU (1) AU1091483A (enExample)
BE (1) BE895718A (enExample)
CA (1) CA1187800A (enExample)
CH (1) CH653554A5 (enExample)
DE (1) DE3302739A1 (enExample)
FR (1) FR2520233A1 (enExample)
GB (1) GB2113547B (enExample)
IT (1) IT1193627B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2141626B (en) * 1983-04-25 1987-01-28 Kao Corp Cinnamic acid derivatives for lightening melanin pigmentation of skin
NZ208338A (en) * 1983-06-09 1987-11-27 Bristol Myers Co Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant
FR2569561B1 (fr) * 1984-08-30 1990-05-18 Oreal Composition stable d'anthraline dans des triglycerides d'acides gras satures d'origine vegetale ayant de 6 a 12 atomes de carbone
US5340579A (en) * 1984-11-20 1994-08-23 Farmaka S.R.L. Method of treating dermatological conditions
DE3603859A1 (de) * 1986-02-07 1987-08-13 Roehm Pharma Gmbh Abwaschbare topische zubereitung zur therapie der psoriasis
US5178881A (en) * 1991-04-12 1993-01-12 Leonard Mackles Anhydrous topical compositions which dry rapidly on contact
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
US6214915B1 (en) * 1998-12-10 2001-04-10 General Electric Company Stabilized thermoplastic compositions
ES2333337T3 (es) 2000-08-29 2010-02-19 Biocon Limited Uso de una composicion farmaceutica que contiene un derivado de acido para-aminofenilacetico para tratar afecciones inflamatorias del tracto gastrointestinal.
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
WO2003099272A1 (en) * 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
WO2004046104A2 (en) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US20050152858A1 (en) * 2003-07-11 2005-07-14 Isp Investments Inc. Solubilizing agents for active or functional organic compounds
US20060067900A1 (en) * 2004-09-29 2006-03-30 Isp Investments Inc. Method and composition for imparting high shine to a polymeric substrate
HUE028158T2 (en) 2004-07-07 2016-12-28 Biocon Ltd Synthesis of bound immunoregulatory compounds
US20060160902A1 (en) * 2004-11-08 2006-07-20 Wiech Norbert L Histone deacetylase inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281225A (enExample) * 1961-07-20
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
GB1504007A (en) * 1976-06-28 1978-03-15 Dermal Lab Ltd Compositions containing dithranol
GB1574090A (en) * 1977-07-06 1980-09-03 Drythanol Ltd Dithranol composition for the treatment of psoriasis
US4326224A (en) * 1977-08-15 1982-04-20 Matsushita Electric Industrial Co. Ltd. Automatic signal compensation recording and reproducing apparatus
DD139793A1 (de) * 1978-11-06 1980-01-23 Waltraud Braun Mittel gegen psoriasis
US4293544A (en) * 1979-03-07 1981-10-06 Finetex Incorporated Fluid and semi-fluid compositions including benzoate esters
US4287214A (en) * 1979-09-24 1981-09-01 Scott Eugene J Van Dithranol compositions stabilized with alpha hydroxyacids
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2492373A1 (fr) * 1980-10-21 1982-04-23 Cird Adducts de dihydroxy-1,8 anthrone-9 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
CA1179271A (fr) * 1981-10-23 1984-12-11 Jean-Francois Grollier Composition epaissie anhydre, stable a l'oxydation, a base d'anthraline ou de l'un de ses derives dans un support constitue d'un alkyl ester d'acide gras et d'un agent epaississant, et son utilisation dans le traitement des maladies de la peau

Also Published As

Publication number Publication date
IT8319306A0 (it) 1983-01-27
DE3302739A1 (de) 1983-08-04
GB2113547B (en) 1985-02-20
GB2113547A (en) 1983-08-10
US4504494A (en) 1985-03-12
GB8302283D0 (en) 1983-03-02
FR2520233B1 (enExample) 1985-05-17
AU1091483A (en) 1983-08-04
FR2520233A1 (fr) 1983-07-29
DE3302739C2 (enExample) 1991-01-24
JPS58134025A (ja) 1983-08-10
CA1187800A (fr) 1985-05-28
IT8319306A1 (it) 1984-07-27
JPH0340009B2 (enExample) 1991-06-17
CH653554A5 (fr) 1986-01-15
IT1193627B (it) 1988-07-21

Similar Documents

Publication Publication Date Title
BE895718A (fr) Composition d'anthralines dans un ester aromatique et utilisation dans le traitement des maladies de la peau et des ongles
BE892299A (fr) Composition cosmetique pour le traitement des cheveux et de la peau
GB2091100B (en) Oily composition for the treatment of keratin substances and the skin
ATE227587T1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
ATE96840T1 (de) Fuer die direkte expression von aktiviertem menschlichen protein-c verwendbare vektoren und zusammensetzungen.
FR2623396B1 (fr) Utilisation de l'ademetionine contre le vieillissement de la peau
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
FR2604435B1 (fr) Peroxydes aromatiques insatures et leur utilisation en therapeutique et cosmetique
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
GB2107587B (en) Composition in the form of a shampoo based on anthralin or a derivative thereof and its use in the treatment of skin diseases
DK295190D0 (da) Kosmetik- og hudbehandlingssammensaetninger
FR2533438B2 (fr) Utilisation en cosmetologie des facteurs de croissance et d'extraits biologiques contenant ceux-ci
ZA882624B (en) Treatment of allergy and composition thereof
BE877629A (fr) Compositions cosmetiques a base de dithioethers pour le traitement de l'etat gras des cheveux et de la peau
FR2612775B1 (fr) Compositions pour la prevention et le traitement de la degenerescence cutanee
EP0269017A3 (en) Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
IT1170238B (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
EP0453658A3 (en) Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases
FR2545720B1 (fr) Composition cosmetique pour le traitement des cheveux et de la peau, contenant des oxathiazinones
ZA79197B (en) Pharmaceutical compositions and their use in the profylaxis and/or treatment of certain diseases
GB8414596D0 (en) Treatment of hair skin and nails
FR2619008B1 (fr) Utilisation de synergistines dans des compositions pharmaceutiques ou cosmetiques anti-acneiques
BE894778A (fr) Composition anhydre stable a base d'anthraline ou d'un derive et son utilisation dans le traitement des maladies de la peau
MA21471A1 (fr) Composition de tourrage et son utilisation dans le tourrage et le post-tourrage des peaux animales .

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: L OREAL

Effective date: 19930131